Core Viewpoint - Hualan Co., Ltd. has signed an agreement to transfer its 30% stake in Jiaxing Yuanfan to Shanghai Hongyuan Investment Group for RMB 12 million, aligning with its strategic layout and future development plans [1] Group 1: Transaction Details - The company will sell its 30% property share in Jiaxing Yuanfan, which includes a subscribed capital of RMB 30 million and a paid-in capital of RMB 12 million, for RMB 12 million [1] - After the transfer, the company will no longer hold any property shares in Jiaxing Yuanfan [1] Group 2: Strategic Implications - The transaction is aimed at improving the company's financial situation by recovering funds and allowing the company to focus on its core business [1] - The move is expected to enhance asset operation efficiency and have a positive impact on the company's financial status [1] - The transaction was conducted under principles of openness, fairness, and justice, ensuring no harm to the interests of the company and its shareholders [1]

Core Viewpoint - Longkun Technology (301305) is committed to focusing on its core business development and aims to enhance long-term value for shareholders through various measures [1] Group 1 - The company is enhancing operational efficiency and optimizing its business structure [1] - Strengthening compliance governance is a key initiative for the company [1] - The company emphasizes effective communication with investors to support its objectives [1]

Core Viewpoint - The company is focusing on enhancing operational efficiency through meticulous cost control and is committed to core product focus and market expansion to improve competitiveness [1]. Group 1 - The company is implementing refined cost management to boost operational efficiency [1]. - The company is concentrating on core products and market expansion to enhance competitiveness [1]. - The company plans to continue focusing on its main business to improve operational quality [1].

Core Viewpoint - The company intends to sell 95% of its stake in Zhuohe (Daishan) Energy Technology Co., Ltd. to Daishan Huafeng Shipbuilding Repair Co., Ltd. for a transaction price of 723 million yuan, which has been approved by the board and supervisory committee, pending shareholder meeting approval [1] Group 1 - The transaction aims to help the company focus on its main business sectors and cutting-edge technology development trends [1] - The sale is expected to optimize the asset structure and improve asset utilization efficiency [1] - The strategic industry layout will be enhanced, thereby increasing the company's core competitiveness and promoting sustainable high-quality development [1] Group 2 - After the transaction is completed, Zhuohe will become an associate company of Zhuoran Co., Ltd. and will no longer be included in the consolidated financial statements [1]

Core Viewpoint - ST凯利 is selling a 51% stake in Jiangsu Runzhitai Medical Technology Co., Ltd. for 10.755 million yuan to Wuxi Youhongtai Enterprise Management Co., Ltd. This transaction aims to focus on core business, optimize resource allocation, and enhance operational efficiency [1] Group 1 - The sixth board meeting of ST凯利 will be held on June 21, 2025, to review the proposal for the sale of the stake [1] - After the transaction, ST凯利 will no longer hold any equity in Runzhitai, and Runzhitai will be excluded from the consolidated financial statements of the company [1] - The sale price for the 51% stake is set at 10.755 million yuan [1]

Core Viewpoint - The company plans to publicly transfer 90.3085% of its subsidiary Shanghai Qinnian Urban Planning Engineering Design Co., Ltd. through the Ningbo Property Exchange to focus on its main business and enhance core competitiveness [1][2][5]. Transaction Overview - The initial listing price for the shares will not be less than the asset appraisal value, with a minimum price set at RMB 521,600 [2]. - The transaction does not constitute a major asset restructuring as defined by relevant regulations, and does not require approval from authorities [2][5]. Basic Information of the Transaction Target - Shanghai Qinnian was established on January 18, 2006, with a registered capital of RMB 100 million, and operates in various engineering and planning sectors [2]. - The company holds 90,308,500 shares of Shanghai Qinnian, representing 90.3085% of its total equity [2]. Financial Performance of the Target Company - As of the latest audited report, Shanghai Qinnian has total assets of approximately RMB 730.20 million and total liabilities of approximately RMB 746.12 million, resulting in a net asset value of approximately -RMB 15.92 million [3]. - The company reported a revenue of approximately RMB 217.67 million and a net loss of approximately RMB 81.63 million [3]. Valuation and Appraisal - The appraisal report indicates that the total equity value of Shanghai Qinnian is RMB 521,600, reflecting an increase of RMB 16.44 million, with a growth rate of 103.28% [3]. Transaction Process and Authorization - The company’s board has proposed to authorize management to handle all matters related to the public transfer, including adjusting the transfer price and signing agreements with the eventual buyer [4][5]. - The authorization will remain effective until the completion of the transaction [5]. Impact on the Company - The transfer of shares is aimed at concentrating resources on core business areas, thereby improving the company's strategic development and long-term interests [5][6]. - Following the completion of the transaction, Shanghai Qinnian will no longer be included in the company's consolidated financial statements [6]. Independent Director's Opinion - The independent directors support the public transfer of shares, stating it will help the company focus on its main business and optimize its asset structure without harming the interests of shareholders, especially minority shareholders [6].

Group 1 - The independent directors of Zhejiang Provincial Weihai Construction Group Co., Ltd. held a special meeting on June 10, 2025, to review the transfer of equity in a controlling subsidiary through public listing [1] - The review concluded that the public transfer of equity in Shanghai Qinnian is beneficial for the company to focus on its main business, optimize its industrial structure, and improve asset utilization efficiency [1] - The independent directors agreed that the equity transfer does not harm the interests of the company and its shareholders, especially minority shareholders, and consented to submit the matter for shareholder meeting approval [1]

Core Viewpoint - The company Shapais (603168.SH) announced the transfer of 100% equity of its wholly-owned subsidiary, Zhejiang Shapais Pharmacy Chain Co., Ltd. to Jiaxing Wanshoutang Pharmaceutical Chain Co., Ltd. for a cash consideration of 500,000 yuan, primarily due to continuous losses and a strategic misalignment of the subsidiary's main business [2][5]. Group 1 - The subsidiary Shapais Pharmacy operates 12 medical insurance stores, and the transfer price includes the licenses, renovations, inventory, and other related assets [5]. - Shapais reported significant financial pressure, with 2023 revenue at 645 million yuan and a net profit decline of 43.9% to 25 million yuan; projected 2024 revenue is expected to drop by 24.96% to 484 million yuan, with a net loss of 121 million yuan, a staggering decline of 583.96% [5]. - The company aims to focus on its core business, optimize asset structure, and improve cash flow through this transfer [5][6]. Group 2 - As of the disclosure date, Wanshoutang Pharmaceutical has paid the first installment of the equity transfer amounting to 300,000 yuan, and the necessary business registration changes have been completed [6]. - Following the completion of this transaction, Shapais will no longer hold any equity in Shapais Pharmacy, and it will be excluded from the company's consolidated financial statements [6].